Magenta therapeutics appoints chief scientific officer and senior vice president, head of regulatory and quality announces transition of jason ryan, chief operating and financial officer

Magenta therapeutics appoints lisa m. olson as chief scientific officer and kevin b. johnson as senior vice president, head of regulatory and quality; announces transition of jason ryan, chief operating and financial officer.magenta therapeutics inc - jason ryan, chief operating and financial officer, will step down from that role at end of september.magenta therapeutics - jason ryan will continue to contribute to magenta in a consulting capacity, and co has commenced a search for a replacement.
DNTH Ratings Summary
DNTH Quant Ranking